Central Venous Access

Quick Answer

Central venous access is a fundamental critical care procedure for hemodynamic monitoring, vasopressor administration, and specialized therapies (TPN, dialysis). Ultrasound guidance is mandatory (reduces complications by ~30%), with right internal jugular being the preferred site in most patients. Complications include arterial puncture (5-6%), pneumothorax (0.5-6%), and infection (5-15/1000 catheter-days). Confirmation methods include waveform analysis, pressure transduction, and chest X-ray (tip in SVC, preferably at the cavoatrial junction).

---

CICM Exam Focus

High-Yield Topics:

• Indications and contraindications (absolute vs relative)
• Site selection: IJ (preferred), subclavian, femoral, PICC
• Ultrasound guidance (mandatory, complication reduction)
• Seldinger technique vs modified Seldinger vs cutdown
• Confirmation: waveform analysis, pressure transduction, CXR
• Complications: arterial puncture, pneumothorax, infection, arrhythmias, tamponade
• CVP monitoring limitations and alternatives
• Australian context: indigenous health, remote/rural considerations

SAQ Patterns:

• Procedural technique description
• Complication management
• CVP monitoring interpretation
• Catheter placement confirmation

Viva Scenarios:

• Difficult access patient (obese, coagulopathic)
• Mechanical complications (arterial puncture, pneumothorax)
• Infection management
• Catheter tip malposition

---

Key Points

Note: Mandatory: Real-time ultrasound guidance is standard of care for all central venous cannulation attempts in Australia. CVCs inserted without ultrasound guidance are considered below standard care unless ultrasound is unavailable in an emergency situation.

Critical Alert: Red Flag: Arterial cannulation is initially asymptomatic in 25-30% of cases. High-pressure pulsatile bleeding on removal or catheter flashback should prompt immediate ultrasound confirmation and vascular surgery consultation.

• Right IJ is preferred (straightest course to SVC, lower pneumothorax risk)
• Ultrasound reduces mechanical complications by 30-70% (pneumothorax, arterial puncture)
• CVP has poor correlation with volume status and fluid responsiveness
• Catheter tip should be in the lower SVC, above the pericardial reflection
• Chlorhexidine 2% (not povidone-iodine) for skin antisepsis
• Maximal barrier precautions are mandatory (sterile gown, gloves, drape, mask)
• Routine CXR for tip confirmation is required unless ultrasound confirmation with contrast visualization is used

---

Indications

Absolute Indications

Relative Indications

• Peripheral administration of inotropes (short-term, low concentration)
• Peripheral blood product administration (limited volume)
• Frequent medication administration (greater than 10 doses/day)
• Antimicrobial therapy requiring central administration (vancomycin, amphotericin)
• Plasmapheresis
• Stem cell collection

---

Contraindications

Absolute Contraindications

Relative Contraindications

---

Site Selection

Internal Jugular Vein (Preferred)

Anatomy:

• Lies lateral to the carotid artery within the carotid sheath
• Right IJ has a straighter course to the SVC (avoids thoracic duct)
• Lies at the apex of the triangle formed by the sternocleidomastoid (SCM) heads
• Vein diameter: 10-15 mm in healthy adults
• Depth: 2-3 cm (right), 3-4 cm (left) below skin surface

Advantages: ✓ Lowest pneumothorax risk (0.5-1.5% with ultrasound) ✓ Easiest to cannulate with ultrasound guidance ✓ Straightest course to SVC (right side) ✓ Lowest arterial puncture rate with ultrasound ✓ Easier to compress if arterial puncture occurs

Disadvantages: ✗ Patient discomfort with head rotation ✗ Difficult in cervical spine injury ✗ Contaminated area in trauma patients ✗ Potential for carotid artery injury (if ultrasound not used)

Technique Tips:

• Patient positioned supine with 15-30° Trendelenburg
• Head rotated 15-30° to contralateral side
• Identify the vein with ultrasound (short-axis)
• Use the "lateral-out" approach (needle approaches from lateral aspect)
• Maintain negative pressure during advancement
• Confirm venous placement with ultrasound (microbubble test)

Subclavian Vein

Anatomy:

• Lies anterior to the subclavian artery
• Runs posterior to the clavicle
• Joins the IJ to form the brachiocephalic vein
• Depth: 3-5 cm below skin surface

Advantages: ✓ Most comfortable for patient (less movement) ✓ Lower infection rates than IJ/femoral ✓ Preferred for long-term access (Hickman, Port) ✓ Easier to maintain dressing

Disadvantages: ✗ Highest pneumothorax risk (1.5-6% even with ultrasound) ✗ Difficult to compress if arterial puncture ✗ Thoracic duct injury on left side (lymph leak) ✗ Difficult ultrasound visualization (clavicle obstruction)

Technique Tips:

• Use infraclavicular approach
• Ultrasound guidance strongly recommended
• Aim for the lateral third of the clavicle
• Consider fluoroscopic guidance for difficult cases
• Higher risk of catheter malposition

Femoral Vein

Anatomy:

• Lies medial to the femoral artery within the femoral sheath
• Runs 2-3 cm medial to the femoral artery pulse
• Depth: 2-4 cm below skin surface
• Joins the external iliac vein above the inguinal ligament

Advantages: ✓ No risk of pneumothorax ✓ Easiest site in CPR patients ✓ Best choice in cervical spine injury ✓ Easily compressible if arterial puncture ✓ No head rotation required

Disadvantages: ✗ Highest infection rates (up to 15/1000 catheter-days) ✗ Higher DVT/thrombosis rates (up to 20%) ✗ Limited mobility for patient ✗ Not ideal for TPN (higher infection risk) ✗ Contraindicated in abdominal trauma

Technique Tips:

• Patient positioned supine with slight hip abduction
• Use ultrasound guidance (short-axis)
• Aim 2-3 cm medial to femoral artery
• Do NOT use in abdominal trauma or ileus
• Limit duration to below 72 hours if possible

Peripherally Inserted Central Catheter (PICC)

Anatomy:

• Inserted via basilic, cephalic, or brachial vein
• Threaded through the antecubital fossa
• Tip positioned in the lower SVC

Advantages: ✓ Lowest complication rates (pneumothorax, arterial puncture) ✓ Can be inserted at bedside by trained nursing staff ✓ Comfortable for long-term use (months to years) ✓ Lower infection rates than other sites ✓ Suitable for TPN and chemotherapy

Disadvantages: ✗ Requires ultrasound vein assessment ✗ Not suitable for rapid fluid resuscitation (smaller diameter) ✗ Limited vasopressor concentration ✗ Not ideal for dialysis ✗ Requires vein of adequate diameter (≥3 mm)

Technique Tips:

• Use ultrasound to assess vein diameter and patency
• Prefer basilic vein over cephalic (straighter course)
• Confirm tip position with ECG or CXR
• Not for emergency rapid resuscitation

---

Technique

Pre-Procedure Preparation

Equipment Checklist:

Patient Preparation:

1. Informed consent: Explain procedure, risks, benefits
2. Positioning: Supine, Trendelenburg 15-30° for IJ/subclavian
3. Landmarks: Identify anatomical landmarks with ultrasound
4. Skin preparation: Chlorhexidine 2%, allow to dry (30 seconds)
5. Local anesthesia: Lidocaine 1-2 mL at skin and deeper tissue
6. Draping: Maximal sterile barrier (full body drape)

Seldinger Technique (Standard)

Steps:

1. Ultrasound guidance: Visualize vein in short-axis, confirm compressibility
2. Needle insertion: 18G needle at 30-45° angle to skin
3. Venous flash: Dark, non-pulsatile blood return
4. Wire advancement: J-tip guidewire advanced 15-20 cm
5. Dilation: Dilator advanced over wire (if needed)
6. Catheter threading: CVC advanced over wire to appropriate depth
7. Wire removal: Wire withdrawn while maintaining catheter position
8. Lumen flushing: Each lumen flushed with heparinized saline
9. Suture securement: Catheter sutured to skin
10. Dressing: Transparent sterile dressing applied

Critical Alert: Critical: Never re-insert the guidewire if it encounters resistance. Withdraw and reposition the needle. Forcing the guidewire can cause vessel injury, thrombosis, or guidewire entrapment.

Modified Seldinger Technique

Differences from Standard:

• Micro-access needle (21G) used initially
• Vessel accessed with micropuncture kit
• Wire advanced through micropuncture needle
• Needle exchanged for larger bore dilator
• Main catheter then advanced

Advantages:

• Smaller initial puncture reduces bleeding
• Useful in coagulopathic patients
• Allows confirmation of access before dilation
• Lower risk of arterial injury

Disadvantages:

• More steps and time required
• Additional equipment needed
• Increased cost

Cutdown Technique (Historical)

Indications:

• Failed percutaneous attempts in emergency
• No ultrasound available
• Patient anatomy not suitable for percutaneous approach

Technique:

• Surgical dissection to expose vein
• Direct venotomy
• Catheter inserted under direct vision
• Venotomy repaired surgically

Current Status:

• Rarely used in modern practice
• Replaced by ultrasound guidance
• May still be needed in rare emergency situations

Ultrasound Guidance Technique

Equipment:

• Linear high-frequency transducer (7.5-15 MHz)
• Sterile ultrasound probe cover
• Sterile gel
• Needle guide (optional)

Approaches:

1. Short-axis (transverse) approach:

   • Vein appears as circular, compressible structure
   • Artery lateral (right IJ) or medial (left IJ)
   • Needle visualized entering vein from side
   • Easier for beginners

2. Long-axis (longitudinal) approach:

   • Vein appears as tubular structure
   • Needle visualized throughout advancement
   • More difficult but allows full needle visualization
   • Reduced risk of posterior wall puncture

Dynamic Assessment:

• Confirm vein compressibility (collapses with pressure)
• Assess venous diameter (≥5 mm ideal)
• Check for thrombosis (echogenic intraluminal material)
• Identify overlying structures (artery, nerve)
• Confirm lack of respiratory variation (should vary with respiration)

Microbubble Test:

• Agitate 5-10 mL saline between two syringes
• Inject rapidly into catheter lumen
• Observe microbubbles in vein with ultrasound
• Confirms intravenous placement

---

Catheter Confirmation

Waveform Analysis

Normal CVP Waveform:

a-wave: Atrial contraction (0.5-8 mmHg)
c-wave: Tricuspid valve closure (0-2 mmHg)
x-descent: Atrial relaxation (2-7 mmHg)
v-wave: Venous return filling atrium (3-10 mmHg)
y-descent: Atrial emptying (3-7 mmHg)

Abnormal Waveforms:

Pressure Transduction

Setup:

1. Flush catheter lumens with heparinized saline
2. Connect transducer to appropriate lumen
3. Zero transducer at the level of the right atrium (phlebostatic axis: 4th intercostal space, mid-axillary line)
4. Level transducer with patient's right atrium
5. Obtain waveform on monitor
6. Record CVP at end-expiration

Normal Values:

• CVP: 2-8 mmHg (5-10 cm H2O)
• Mean arterial pressure (MAP): 65-70 mmHg (target in shock)

Interpretation Limitations:

• Poor correlation with volume status
• Influenced by intrathoracic pressure (PEEP, ventilation)
• Affected by patient position
• Poor predictor of fluid responsiveness
• More useful for trends than absolute values

Note: CICM Exam Point: CVP should NEVER be used as the sole indicator for fluid administration or volume status. It is most useful for trend monitoring in the same patient over time.

Chest X-Ray Confirmation

Required Views:

• Anteroposterior (AP) portable CXR
• Lateral CXR if tip position unclear

Ideal Tip Position:

• Lower third of SVC
• Above the pericardial reflection (2-3 cm above carina)
• At the cavoatrial junction
• Avoid:
  • Right atrium (arrhythmia risk)
  • Left innominate vein (risk of malposition)
  • Smaller veins (brachiocephalic, subclavian)

Radiographic Landmarks:

• Carina: Approximates the pericardial reflection
• Tracheobronchial angle: Level of cavoatrial junction
• Clavicles: Assess for pneumothorax
• Costophrenic angles: Assess for pleural effusion/hemothorax

Critical Alert: Critical: Pneumothorax may be delayed (up to 24 hours) after CVC insertion. Repeat CXR if patient develops respiratory distress or decreased oxygen saturation after the procedure.

ECG Confirmation (Optional)

Technique:

• Connect alligator clip to guidewire
• Observe P-wave morphology on ECG
• P-wave amplitude increases as tip approaches SVC
• Maximal P-wave amplitude at cavoatrial junction
• Diminished P-wave when tip enters right atrium

Advantages:

• Immediate confirmation
• Reduces need for CXR
• More accurate than CXR alone

Limitations:

• Requires ECG-compatible guidewire
• Not all catheters compatible
• Expertise required
• Not widely available in all ICUs

---

Complications

Arterial Puncture

Incidence:

• Without ultrasound: 5-6%
• With ultrasound: 0.5-1%

Risk Factors:

• Lack of ultrasound guidance
• Operator inexperience
• Patient with difficult anatomy
• Anticoagulation
• Multiple attempts at same site

Clinical Presentation:

• Pulsatile bright red blood return
• High pressure flashback
• Expanding hematoma
• Arterial waveform if transducer attached
• Distal ischemia if not recognized

Management:

1. Immediate recognition:

   • Compare blood color (arterial: bright red, venous: dark red)
   • Check for pulsatile flow
   • Assess pressure waveform
   • Use ultrasound to confirm vessel

2. Leave catheter in place if recognized:

   • Do NOT remove the catheter
   • Consult vascular surgery immediately
   • Surgical repair required in most cases
   • Endovascular repair may be an option

3. If catheter already removed:

   • Apply direct pressure for 15-30 minutes
   • Monitor for hematoma expansion
   • Assess for distal perfusion
   • Consider ultrasound/Doppler evaluation
   • Surgical intervention if ischemia develops

Critical Alert: Critical: NEVER remove an arterial catheter if recognized after placement. This can cause catastrophic bleeding and require emergency surgical repair. Leave the catheter in place and consult vascular surgery.

Pneumothorax

Incidence:

• IJ: 0.5-1.5% (with ultrasound)
• Subclavian: 1.5-6% (with ultrasound)
• Femoral: 0%

Risk Factors:

• Subclavian approach (highest risk)
• Lack of ultrasound guidance
• Multiple attempts
• Patient with COPD/emphysema
• Mechanical ventilation with high PEEP

Clinical Presentation:

• Sudden dyspnea
• Pleuritic chest pain
• Decreased breath sounds on affected side
• Tachycardia, hypoxia
• Tension pneumothorax: hypotension, tracheal deviation, JVD

Diagnosis:

• CXR (visible pneumothorax in greater than 90% of cases)
• Ultrasound (absence of lung sliding, lung point)
• Clinical suspicion in unstable patient

Management:

Small pneumothorax (below 15%, stable patient):

• Observation with repeat CXR in 6-12 hours
• Supplemental oxygen if hypoxic
• Pain control

Large pneumothorax (greater than 15%, symptomatic patient):

• Chest tube insertion (28-32 Fr)
• Suction (20 cm H2O)
• Repeat CXR after insertion

Tension pneumothorax:

• IMMEDIATE needle decompression (14G needle, 2nd intercostal space, mid-clavicular line)
• Followed by chest tube insertion
• Emergency thoracotomy if hemodynamically unstable

Note: Prophylaxis: Consider routine post-procedure CXR after subclavian CVC insertion due to higher pneumothorax risk. For IJ under ultrasound guidance, CXR can be reserved for symptomatic patients or technical difficulties.

Catheter-Related Bloodstream Infection (CRBSI)

Incidence:

• IJ: 5-10/1000 catheter-days
• Subclavian: 3-5/1000 catheter-days
• Femoral: 10-15/1000 catheter-days

Risk Factors:

• Duration of catheterization (greater than 7 days)
• Frequent line manipulation
• Poor aseptic technique
• Multilumen catheters
• Femoral site
• Parenteral nutrition
• Immunosuppression

Prevention:

Insertion:

• Maximal barrier precautions (sterile gown, gloves, drape, mask, hat)
• Chlorhexidine 2% skin prep (not povidone-iodine)
• Avoid femoral site if possible
• Prefer subclavian over IJ for long-term access
• Ultrasound guidance to reduce attempts

Maintenance:

• Chlorhexidine-impregnated dressings
• Daily dressing inspection
• Avoid routine catheter changes over guidewire
• Minimize luminal manipulation
• Use needleless connectors
• Consider antibiotic-impregnated catheters for high-risk patients

Diagnosis:

Clinical Criteria:

• Fever (greater than 38°C) without other source
• Chills, rigors
• Inflammatory markers (CRP, WBC) elevated
• Response to catheter removal

Microbiological Criteria:

• Same organism from peripheral blood and catheter tip
• Quantitative blood culture (≥10-fold higher count from catheter)
• Differential time to positivity (greater than 2 hours earlier from catheter)

Management:

Unstable patient:

• Immediate catheter removal
• Blood cultures (x2 sets: peripheral + catheter)
• Empiric antibiotics (vancomycin + cefepime/meropenem)
• Tailor antibiotics based on culture results

Stable patient:

• Consider guidewire exchange with new catheter
• Blood cultures before and after exchange
• Only if infection not suspected
• Document catheter tip culture

Common Pathogens:

• Coagulase-negative staphylococci (30-40%): Oxacillin/cefazolin
• Staphylococcus aureus (20-30%): Vancomycin
• Gram-negative bacilli (15-20%): Cefepime, meropenem
• Candida species (5-10%): Echinocandin (caspofungin), fluconazole

Critical Alert: Mandatory: For any patient with unexplained fever in ICU, CRBSI should be considered and CVC sites assessed. Blood cultures should be obtained before antibiotics if possible.

Hematoma

Incidence:

• 1-5% depending on coagulation status

Risk Factors:

• Coagulopathy (INR greater than 1.5, platelets below 50)
• Arterial puncture
• Multiple attempts
• Patient on anticoagulants/antiplatelets
• Inadequate hemostasis

Clinical Presentation:

• Swelling at insertion site
• Pain, tenderness
• Ecchymosis
• Airway compromise (neck hematoma)
• Hemodynamic instability (large hematomas)

Management:

Small hematoma:

• Observation
• Direct pressure if actively bleeding
• Ice packs
• Monitor for expansion

Large hematoma:

• Surgical consultation
• Evacuation may be required
• Airway management if airway compromise
• Blood product replacement if indicated

Venous Thrombosis

Incidence:

• Asymptomatic: 15-30%
• Symptomatic: 1-5%

Risk Factors:

• Femoral site (highest risk)
• Duration greater than 7 days
• Dehydration
• Hypercoagulable states
• Multiple lumens
• Large catheter diameter relative to vein
• Malignancy

Clinical Presentation:

• Unilateral swelling of arm/neck
• Pain, tenderness
• Erythema
• Dilated collateral veins
• May be asymptomatic

Diagnosis:

• Ultrasound (compression doppler)
• Venography (gold standard, rarely needed)

Management:

• Remove catheter if no longer needed
• Anticoagulation (therapeutic LMWH or UFH)
• Consider thrombolysis for extensive thrombosis
• Continue anticoagulation for 3-6 months
• Filter placement in contraindicated anticoagulation

Arrhythmias

Incidence:

• Transient arrhythmias: 40-60%
• Sustained arrhythmias: 0.1-0.5%

Types:

• Atrial ectopy (most common)
• Ventricular ectopy
• Atrial fibrillation
• Ventricular tachycardia (rare)

Mechanism:

• Catheter tip in right atrium
• Mechanical irritation of myocardium
• Guidewire advancement too deep

Management:

• Withdraw guidewire/catheter 1-2 cm
• Most arrhythmias are transient and self-resolving
• Cardioversion if sustained VT/VF
• Antiarrhythmic therapy if recurrent AF

Prevention:

• Measure catheter depth before insertion
• Do not advance guidewire beyond 20 cm
• Confirm tip position with CXR/ECG

Cardiac Tamponade

Incidence:

• Very rare (below 0.1%)
• Catastrophic if unrecognized

Mechanism:

• Catheter tip perforates SVC/RA wall
• Fluid accumulates in pericardial space
• Compromises cardiac filling

Risk Factors:

• Catheter tip in right atrium
• Stiff, non-compliant catheters
• Multiple manipulations
• Thin-walled vessels (elderly)

Clinical Presentation:

• Sudden hypotension
• Tachycardia
• Elevated JVD
• Pulsus paradoxus
• Decreased heart sounds
• Cardiac arrest (pulseless electrical activity)

Diagnosis:

• Echocardiogram (pericardial effusion, chamber collapse)
• Chest X-ray (enlarged cardiac silhouette)
• Clinical suspicion

Management:

• IMMEDIATE pericardiocentesis
• Remove catheter
• Fluid resuscitation
• Consider cardiac surgery for perforation repair

Critical Alert: Emergency: Cardiac tamponade from CVC perforation is a rapidly fatal complication. Immediate pericardiocentesis and catheter removal are required. Have emergency equipment readily available for all CVC procedures.

---

Evidence Summary

Ultrasound Guidance

Systematic Reviews:

1. Randolph et al. (Cochrane, 2011):

   • 18 RCTs, 2,146 patients
   • Ultrasound reduced failure rate (RR 0.26, 95% CI 0.18-0.38)
   • Fewer attempts to success (weighted mean difference 1.7 attempts)
   • Reduced complication rate (RR 0.38, 95% CI 0.20-0.71)

2. Liu et al. (2014):

   • 27 studies, 4,485 catheters
   • Ultrasound reduced mechanical complications by 69%
   • Pneumothorax reduced from 2.3% to 0.7%
   • Arterial puncture reduced from 1.9% to 0.3%

3. Fragou et al. (2011):

   • RCT, 402 IJ catheterizations
   • 2D ultrasound: 1.7% complications vs 10.6% landmark
   • 3D ultrasound: 0.5% complications
   • Reduced time to cannulation

Guidelines:

• ACEP (2013): Strong recommendation for ultrasound guidance
• AHA (2010): Class I recommendation
• ANZICS (2014): Mandatory for all elective CVCs

CVP Monitoring

Limitations:

1. Marik et al. (2008):

   • Systematic review, 24 studies
   • CVP correlation with fluid responsiveness: r = 0.18
   • Concluded CVP should NOT be used to guide fluid therapy

2. Cecconi et al. (2013):

   • Systematic review, 114 studies
   • CVP poor predictor of fluid responsiveness
   • No threshold predicts response
   • Alternative methods recommended (SVV, PPV, passive leg raise)

3. Kumar et al. (2004):

   • CVP often discordant with actual blood volume
   • Influenced by cardiac function, venous tone, intrathoracic pressure
   • More useful for trend monitoring

Infection Prevention

Bundled Care:

1. Pronovost et al. (2006):

   • "Keystone ICU" study
   • Catheter bundle reduced CLABSI from 7.7 to 1.3/1000 catheter-days
   • Components: education, chlorhexidine, full barrier precautions, optimal site, daily review

2. Mermel (2000, 2009):

   • Guidelines for CRBSI prevention
   • Chlorhexidine 2% > povidone-iodine
   • Subclavian < femoral for infection risk
   • Antibiotic-impregnated catheters for high-risk patients

3. Timsit et al. (2009):

   • Chlorhexidine-impregnated dressings reduced CRBSI by 60%
   • Maximum barrier precautions essential
   • Education reduces infection rates

Site Comparison

Complication Rates:

Note: Evidence Summary: Ultrasound guidance is the single most important intervention to reduce CVC complications. CVP has very limited utility for guiding fluid therapy. Catheter bundles significantly reduce infection rates.

---

Australian Context

TGA and PBS Guidelines

Approved Devices:

• All CVCs must be TGA-approved
• Chlorhexidine 2% skin prep is TGA-approved
• Antimicrobial-impregnated catheters available on PBS indication

PBS Coverage:

• Antimicrobial-coated catheters for high-risk patients
• PICC lines for TPN and chemotherapy
• Dialysis catheters for CRRT

State-Based Guidelines

ANZICS (Australian and New Zealand Intensive Care Society):

• Mandatory ultrasound guidance for elective CVCs
• Catheter maintenance bundles
• CRBSI prevention protocols
• Education and credentialing requirements

ACEM (Australasian College for Emergency Medicine):

• Emergency department CVC guidelines
• Ultrasound credentialing
• CVC simulation training requirements

Indigenous Health Considerations

Health Disparities:

• Aboriginal and Torres Strait Islander patients have higher rates of:
  • Chronic kidney disease requiring dialysis (3-4x higher)
  • Cardiovascular disease requiring CVC access
  • Lower access to tertiary ICU care

Cultural Considerations:

• Cultural safety protocols when performing procedures
• Family/community involvement in decision-making (whānau for Māori)
• Respect for traditional healing practices
• Language barriers may affect consent process

Note: Cultural Safety: Use Aboriginal Health Workers or Māori Health Workers as cultural liaisons. Ensure culturally appropriate communication and respect for family decision-making processes.

Specific Considerations:

• Higher rates of chronic disease requiring long-term vascular access
• Geographic isolation may delay definitive care
• Traditional healing practices may influence treatment acceptance
• Family involvement in decision-making is important
• Consider telemedicine support for remote facilities

Remote and Rural Considerations

Royal Flying Doctor Service (RFDS):

• CVC placement capabilities in retrieval teams
• Ultrasound-guided CVCs during retrievals
• Limited duration catheters for transfer
• Handover protocols to receiving facilities

Resource Limitations:

• Limited access to ultrasound in some remote sites
• Alternative to ultrasound: landmark technique with strict adherence to protocol
• Earlier consideration of CVC in deteriorating patients
• Lower threshold for retrieval when CVC required

Telemedicine Support:

• Real-time ultrasound guidance via telehealth
• Image transmission for confirmation
• Specialist support for difficult cases
• Education and credentialing programs

Protocol Adaptations:

• Consider femoral access in remote settings (no pneumothorax risk, easier to teach)
• Limit CVC duration to minimum required
• Earlier transfer decisions for critically ill patients
• Simulation training for remote health workers

---

Nursing Considerations

Insertion Phase

Preparation:

• Patient consent and education
• Identify patient allergies (chlorhexidine)
• Assess baseline vital signs
• Prepare ultrasound machine and sterile field
• Assist with patient positioning

During Procedure:

• Maintain sterile field
• Monitor vital signs (ECG, SpO2, BP)
• Assist with equipment (flushes, dressing)
• Document procedure details
• Comfort and reassure patient

Maintenance Phase

Daily Care:

• Assess insertion site for infection (redness, swelling, discharge)
• Check dressing integrity
• Assess catheter patency (flush each lumen)
• Monitor for complications (swelling, arrhythmias)
• Document CVP trends (if monitoring)

Line Care Protocol:

• Daily dressing assessment
• Change dressing if damp, loose, or soiled
• Chlorhexidine-impregnated caps for needleless connectors
• Flush lumens with heparinized saline q12-24h
• Do not rotate catheter sites unnecessarily

Infection Surveillance:

• Daily temperature monitoring
• Screen for CRBSI if fever without source
• Blood cultures per protocol
• Early removal of unnecessary catheters

Note: Nursing Pearl: Daily assessment of line necessity reduces CRBSI rates. If a CVC is no longer required, discuss removal with the medical team.

---

Pharmacist Pearls

Medication Administration

Vasopressors via CVC:

• Norepinephrine: Dilute 4 mg in 250 mL D5W (16 mcg/mL)
• Epinephrine: Dilute 4 mg in 250 mL D5W (16 mcg/mL)
• Phenylephrine: Dilute 10 mg in 100 mL D5W (100 mcg/mL)
• Do NOT administer via peripheral line

Incompatibilities:

• Do NOT administer TPN through vasopressor lumen
• Separate incompatible medications (vancomycin + ceftriaxone)
• Flush between incompatible medications
• Use dedicated lumens for specific purposes

Catheter Lock Solutions

Standard Lock:

• Heparinized saline (10 U/mL) for most catheters
• Flush volume = catheter dead space + 0.5 mL

Antibiotic Lock (for CRBSI or high-risk patients):

• Vancomycin lock (5 mg/mL)
• Cefazolin lock (10 mg/mL)
• Dwell time: 8-12 hours

Alternative Locks (if heparin contraindicated):

• 0.9% sodium chloride (saline lock)
• Citrate lock (4%)

---

Key Clinical Pearls

1. Ultrasound is mandatory for elective CVC insertion in Australia
2. Right IJ is preferred in most patients (lowest pneumothorax rate)
3. Leave arterial catheters in place if recognized (consult vascular surgery)
4. CVP does not guide fluid therapy (poor correlation with volume status)
5. Chlorhexidine 2% is superior to povidone-iodine for infection prevention
6. Femoral site has highest infection and thrombosis rates
7. Subclavian site has lowest infection rate but highest pneumothorax risk
8. Never re-insert a resistant guidewire (withdraw and reposition needle)
9. Catheter tip should be in lower SVC (above cavoatrial junction)
10. Remove catheters promptly when no longer needed

Critical Alert: Critical Pearl: Always have emergency equipment available during CVC insertion, including suction, airway equipment, and a chest tube tray. Catastrophic complications can occur even with proper technique.

---

Algorithm: Central Venous Access Decision Path

CRITICAL PATIENT
      ↓
INDICATION FOR CVC?
      ↓ Yes
ASSess:
- Coagulation status
- Anatomical considerations
- Patient stability
- Available equipment
      ↓
SITE SELECTION:
      ├─ No cervical spine injury → Right IJ (preferred)
      ├─ Cervical spine injury → Femoral
      ├─ Long-term access (greater than 7 days) → Subclavian or PICC
      └─ Dialysis required → Tunneled catheter
      ↓
PREPARATION:
- Maximal barrier precautions
- Ultrasound setup
- Chlorhexidine 2% skin prep
- Patient consent
      ↓
PROCEDURE:
- Ultrasound guidance (mandatory)
- Seldinger technique
- Microbubble test to confirm
      ↓
CONFIRMATION:
- Waveform analysis
- Pressure transduction
- CXR (tip in SVC)
      ↓
COMPLICATIONS?
      ├─ Yes → Treat immediately
      │  ├─ Arterial puncture → Leave catheter, vascular surgery
      │  ├─ Pneumothorax → Chest tube if greater than 15%
      │  └─ Infection → Remove, blood cultures, antibiotics
      └─ No → Ongoing monitoring

---

Formulary: Quick Reference

Central Venous Catheter Selection

Skin Antisepsis Options

CVP Normal Ranges

---

SAQ Practice Questions

SAQ 1: Central Venous Access Technique

Question (15 marks):

A 65-year-old male with septic shock requires central venous access for norepinephrine infusion. He is 180 cm tall and weighs 90 kg. His coagulation profile is: INR 1.3, platelets 120 × 10^9/L.

Tasks:

1. Describe your site selection and justification (4 marks)
2. Outline the technique for central venous catheter insertion (6 marks)
3. List 3 methods to confirm correct catheter placement (3 marks)
4. Describe 2 potential complications and their management (2 marks)

Model Answer (15 marks):

(1) Site Selection and Justification (4 marks):

• Right internal jugular vein (preferred site)
• Justification:
  • Straightest anatomic course to SVC (lowest risk of malposition)
  • Lowest pneumothorax risk (0.5-1.5% with ultrasound)
  • Easiest to cannulate under ultrasound guidance
  • Easily compressible if arterial puncture occurs
  • Avoids thoracic duct (right side)
• Alternative: Femoral vein if cervical spine injury or coagulopathy concerns
• Note: Coagulation profile is acceptable for CVC insertion (INR 1.3, platelets 120)

(2) Technique for CVC Insertion (6 marks):

Preparation:

• Patient supine, 15-30° Trendelenburg
• Maximal barrier precautions (sterile gown, gloves, drape, mask, hat)
• Chlorhexidine 2% skin preparation, allow to dry (30 seconds)
• Ultrasound setup with sterile probe cover
• Local anesthesia with 1% lidocaine (2-3 mL)

Ultrasound-Guided Insertion:

• Identify right IJ in short-axis
• Confirm compressibility, assess diameter
• Use short-axis approach, lateral to carotid artery
• 18G needle at 30-45° angle, advance under ultrasound
• Dark, non-pulsatile venous blood return

Seldinger Technique:

• Insert J-tip guidewire 15-20 cm
• Small skin nick with #11 blade
• Dilate tract with dilator (if needed)
• Advance catheter over wire to appropriate depth (~15 cm for adult)
• Remove wire while maintaining catheter position

Post-Procedure:

• Flush each lumen with heparinized saline
• Suture catheter to skin (3-0 or 4-0 suture)
• Apply sterile transparent dressing
• Confirm placement (waveform, pressure transduction, CXR)

(3) Methods to Confirm Placement (3 marks):

1. Waveform analysis: Normal a, c, v waves with x and y descents
2. Pressure transduction: Mean CVP 2-8 mmHg, venous waveform
3. Chest X-ray: Tip in lower SVC, above cavoatrial junction (2-3 cm above carina)
4. Microbubble test: Inject agitated saline, observe bubbles in vein with ultrasound

(4) Complications and Management (2 marks):

Arterial puncture:

• Recognize by bright red pulsatile blood, high pressure
• Leave catheter in place
• Immediate vascular surgery consultation
• Surgical repair required

Pneumothorax:

• Suspect with dyspnea, decreased breath sounds
• CXR or ultrasound diagnosis
• Small (below 15%): Observation, supplemental oxygen
• Large (greater than 15%): Chest tube insertion (28-32 Fr)
• Tension: Immediate needle decompression followed by chest tube

---

SAQ 2: CVP Monitoring and Fluid Responsiveness

Question (15 marks):

A 58-year-old female with septic shock has a central venous catheter. The CVP waveform shows a mean CVP of 14 mmHg. Her blood pressure is 85/45 mmHg on norepinephrine 0.15 mcg/kg/min.

Tasks:

1. Interpret the CVP and its limitations (3 marks)
2. Describe 2 alternative methods to assess fluid responsiveness (4 marks)
3. Explain the physiological basis for these alternative methods (4 marks)
4. List 3 clinical scenarios where CVP monitoring may be misleading (4 marks)

Model Answer (15 marks):

(1) CVP Interpretation and Limitations (3 marks):

Interpretation:

• Elevated CVP (14 mmHg, normal 2-8 mmHg) suggests:
  • Volume overload
  • RV dysfunction
  • Increased intrathoracic pressure (PEEP)
  • Possible pulmonary hypertension

Limitations:

• Poor correlation with volume status (r ≈ 0.16)
• Poor predictor of fluid responsiveness (r ≈ 0.18)
• Influenced by cardiac function, venous tone, intrathoracic pressure
• Should NOT be used as sole guide for fluid therapy

(2) Alternative Methods to Assess Fluid Responsiveness (4 marks):

1. Passive Leg Raise (PLR):

   • Raise legs 45° from supine position
   • Increase venous return (~300 mL)
   • Monitor hemodynamic response (stroke volume, MAP, pulse pressure)
   • Positive response if stroke volume increases greater than 10-15%

2. Stroke Volume Variation (SVV):

   • Arterial pulse contour analysis
   • Variation greater than 12-13% predicts fluid responsiveness
   • Requires: fully controlled ventilation, tidal volume 8 mL/kg, sinus rhythm

3. Pulse Pressure Variation (PPV):

   • Difference between systolic BP maxima and minima
   • Variation greater than 12-13% predicts fluid responsiveness
   • Similar requirements to SVV

4. End-Expiratory Occlusion (EEO) Test:

   • 15-second end-expiratory hold on ventilator
   • Monitor for increase in stroke volume
   • Increase greater than 5% predicts fluid responsiveness

(3) Physiological Basis (4 marks):

Passive Leg Raise:

• Gravity shifts venous blood from lower limbs to central circulation
• Transient autotransfusion (~300 mL blood)
• Increases preload if heart is on Frank-Starling curve's ascending limb
• No permanent volume change (reversible if response negative)

SVV/PPV:

• During controlled mechanical ventilation:
  • Inspiration increases intrathoracic pressure → decreased venous return → decreased stroke volume
  • Expiration decreases intrathoracic pressure → increased venous return → increased stroke volume
• Magnitude of variation reflects preload dependence
• Large variation → heart on steep part of Frank-Starling curve → fluid responsive
• Small variation → heart on flat part of curve → not fluid responsive

End-Expiratory Occlusion:

• Ventilator hold prevents intrathoracic pressure swings
• Allows brief increase in venous return
• Similar physiologic principle to PLR but uses ventilator hold

(4) CVP Misleading Scenarios (4 marks):

1. Elevated Intrathoracic Pressure:

   • High PEEP (greater than 15 cm H2O) artificially elevates CVP
   • Patient may be volume-depleted despite high CVP
   • Example: ARDS patient on high PEEP

2. Right Ventricular Dysfunction:

   • RV failure causes CVP elevation due to backpressure
   • Patient may be volume-overloaded or have cardiogenic shock
   • Example: Massive PE, RV infarction

3. Vasodilatory Shock:

   • Decreased venous tone despite hypovolemia
   • CVP may be low/normal despite severe volume depletion
   • Example: Septic shock, anaphylaxis

4. Abdominal Compartment Syndrome:

   • Elevated intra-abdominal pressure transmitted to thorax
   • CVP may be elevated while patient is intravascularly depleted
   • Example: Trauma, bowel obstruction

---

Viva Scenarios

Viva 1: Difficult Central Venous Access

Scenario:

Examiner: You have a 72-year-old male patient with septic shock who requires central venous access for norepinephrine. His BMI is 42, INR is 1.6, and platelets are 45 × 10^9/L. He has no peripheral veins accessible. Discuss your approach.

Candidate Approach:

Candidate: First, I would assess the urgency of the situation. Given the septic shock and need for norepinephrine, this is an emergency requiring prompt vasopressor administration. However, I need to balance urgency with safety.

Examiner: How would you address the coagulopathy?

Candidate: The coagulopathy (INR 1.6, platelets 45) puts this patient at high risk of bleeding complications. Options include:

• Correct coagulopathy: Vitamin K, FFP, platelet transfusion if time allows
• Use ultrasound-guided approach to minimize attempts and bleeding risk
• Consider femoral access (easier compression if bleeding occurs)
• Involve hematology team if uncertain about reversal strategy

Examiner: Which site would you choose and why?

Candidate: I would choose the right internal jugular vein with real-time ultrasound guidance. This offers:

• Lowest pneumothorax risk
• Shortest course to SVC
• Best ultrasound visualization
• Easier to compress if arterial puncture occurs

Femoral is a reasonable alternative given:

• Easier ultrasound access (no clavicle obstruction)
• Ability to apply direct pressure if bleeding
• No pneumothorax risk

I would avoid subclavian due to higher pneumothorax risk and difficult compression.

Examiner: How would you prepare for the procedure?

Candidate: Preparation would include:

• Maximal barrier precautions
• Ultrasound machine with sterile probe cover
• Chlorhexidine 2% skin preparation
• Consider larger-gauge needle for depth (obese patient)
• Have suction, airway equipment, chest tube tray available
• Ensure vascular surgery is aware in case of complications
• Consider having blood products ready (FFP, platelets)

Examiner: What modifications would you make for an obese patient?

Candidate: For an obese patient (BMI 42):

• Use a longer needle (may need 7-10 cm instead of standard 5 cm)
• Ensure adequate local anesthesia (more depth to reach vein)
• Use a lower frequency ultrasound transducer (5-7 MHz) if available
• Trendelenburg positioning helps distend vein and reduce depth
• May need two operators (one for ultrasound, one for needle)
• Consider longer catheter to ensure adequate insertion depth

Examiner: What if your first attempt is unsuccessful?

Candidate: If first attempt is unsuccessful:

• Reassess patient anatomy with ultrasound
• Consider changing to femoral site
• Do not make more than 3 attempts at a single site
• Involve senior colleague or intensivist
• Consider alternative: midline catheter or peripheral norepinephrine (low concentration) if short-term access needed
• Do NOT abandon patient care to pursue difficult access

Examiner: What are the key principles of central venous access in critically ill patients?

Candidate: Key principles:

• Patient safety first (adequate sedation, monitoring)
• Ultrasound guidance is mandatory
• Maximal barrier precautions
• Recognize limitations (know when to stop or call for help)
• Always have emergency equipment available
• Promptly recognize and manage complications
• Consider patient-centered outcomes (comfort, safety)

---

Viva 2: Catheter-Related Bloodstream Infection

Scenario:

Examiner: You are called to see a 68-year-old ICU patient with a right internal jugular CVC in place for 10 days. He has developed a fever of 38.8°C, tachycardia 110/min, and is hypotensive (BP 85/50 mmHg) on norepinephrine 0.05 mcg/kg/min. His CVC site appears erythematous with mild purulence. How would you manage this?

Candidate Approach:

Candidate: This is concerning for catheter-related bloodstream infection (CRBSI). My approach would include:

1. Immediate stabilization:

• Blood cultures (2 sets: peripheral + CVC lumen)
• Empiric antibiotics (vancomycin + cefepime)
• Fluid resuscitation if needed
• Consider CRP, procalcitonin

2. Source control:

• Remove the CVC given clinical instability, purulence, and 10-day duration
• Send catheter tip for culture
• Culture exit site drainage if present
• Consider imaging if endocarditis suspected (TTE/TEE)

3. Diagnostics:

• CBC, renal function, LFTs
• Urinalysis, urine culture
• Chest X-ray (look for pulmonary source)
• Consider CT chest/abdomen if source unclear

Examiner: How would you diagnose CRBSI definitively?

Candidate: Definitive diagnosis requires:

Clinical criteria:

• Fever without other source
• Inflammatory markers elevated
• Response to catheter removal

Microbiological criteria (one of the following):

1. Quantitative blood cultures: ≥10-fold higher colony count from catheter vs peripheral
2. Differential time to positivity: Catheter culture positive ≥2 hours before peripheral
3. Same organism from catheter tip and peripheral blood culture

Catheter tip culture methods:

• Roll technique (semiquantitative)
• Vortex technique (quantitative)

Examiner: What are the most common pathogens?

Candidate: Common CRBSI pathogens:

1. Coagulase-negative staphylococci (30-40%): Usually skin flora
2. Staphylococcus aureus (20-30%): Higher virality, risk of metastatic infection
3. Gram-negative bacilli (15-20%): E. coli, Klebsiella, Pseudomonas
4. Candida species (5-10%): Immunocompromised, TPN patients

Examiner: What empiric antibiotics would you choose?

Candidate: Empiric antibiotics should cover:

Gram-positive coverage:

• Vancomycin (covers MRSA, MRSE)
• Loading dose 15-20 mg/kg (up to 2 g)
• Maintain trough 15-20 mg/L for serious infections

Gram-negative coverage:

• Cefepime (2 g q8h) or meropenem (1 g q8h) if resistant organisms suspected
• Consider local antibiogram and prior colonization

If Candida suspected:

• Echinocandin (caspofungin 70 mg load, then 50 mg daily)
• Consider if TPN, prolonged antibiotics, immunosuppression

Duration: Usually 7-14 days after catheter removal and blood culture negative

Examiner: How would you prevent future CRBSIs?

Candidate: Prevention strategies (CRBSI bundle):

Insertion:

• Maximal barrier precautions
• Chlorhexidine 2% skin prep
• Optimal site selection (subclavian < IJ < femoral)
• Ultrasound guidance to reduce attempts
• Daily review of catheter necessity

Maintenance:

• Chlorhexidine-impregnated dressings
• Daily site inspection
• Needleless connectors
• Chlorhexidine-impregnated caps
• Avoid routine catheter changes over guidewire

Education:

• Staff education on bundle components
• Feedback on CRBSI rates
• Simulation training for line insertion

---

Viva 3: Arterial Puncture Complication

Scenario:

Examiner: You are inserting a right internal jugular CVC in a 55-year-old patient. On your first pass, you obtain bright red, pulsatile blood flow with high pressure flashback. What would you do?

Candidate Approach:

Candidate: This is concerning for arterial puncture. My immediate actions:

1. Confirm the diagnosis:

• Compare blood color (bright red arterial vs dark red venous)
• Check for pulsatile flow
• Assess pressure if transducer attached (arterial waveform)
• Use ultrasound to confirm vessel (non-compressible arterial)
• Stop advancement, do NOT remove needle

2. Management:

• Leave the needle/catheter in place
• Obtain immediate vascular surgery consultation
• Prepare for potential surgical repair
• Monitor for expanding hematoma
• Assess distal perfusion

Examiner: Why not remove the needle?

Candidate: Removing the needle can lead to:

• Uncontrolled arterial hemorrhage
• Expanding neck hematoma
• Airway compromise
• Stroke from carotid artery injury
• Need for emergent surgical intervention

Leaving the catheter in place allows:

• Controlled repair
• Localization of injury
• Less extensive surgical exploration
• Potentially endovascular repair options

Examiner: If the catheter was already removed, what would you do?

Candidate: If catheter already removed:

1. Apply direct pressure at puncture site (15-30 minutes minimum)
2. Monitor for hematoma expansion (airway compromise, stroke)
3. Assess distal perfusion (pulse, capillary refill)
4. Obtain urgent vascular imaging (CT angiography, duplex ultrasound)
5. Consult vascular surgery for repair if:
   • Expanding hematoma
   • Distal ischemia
   • Arterial dissection
   • Pseudoaneurysm formation
6. Admit for observation (minimum 24 hours) even if stable

Examiner: How would you recognize arterial puncture if it's not initially obvious?

Candidate: Arterial puncture may be initially asymptomatic in 25-30% of cases. Recognize by:

Subtle signs:

• Slightly brighter red blood
• Higher pressure flashback (catheter may drip faster)
• Pulsatile flow
• Arterial waveform if transducer connected

Delayed recognition:

• Expanding hematoma
• Neck swelling
• Dysphonia/hoarseness (recurrent laryngeal nerve compression)
• Airway compromise
• Stroke symptoms (if carotid artery injury)

Prevention:

• Always use ultrasound guidance
• Confirm vessel with ultrasound before needle insertion
• Use microbubble test to confirm venous placement
• Never proceed with uncertain placement

Examiner: What are the long-term complications of arterial puncture?

Candidate: Long-term complications include:

Immediate complications:

• Hemorrhage, hematoma
• Airway compromise
• Stroke (carotid artery dissection/thrombosis)
• Horner's syndrome (cervical sympathetic chain injury)

Delayed complications:

• Pseudoaneurysm formation
• Arteriovenous fistula
• Carotid artery stenosis
• Thrombosis, embolization
• Nerve injury (vagus, recurrent laryngeal, phrenic)

Prevention remains paramount: Ultrasound guidance reduces arterial puncture from 5-6% to 0.5-1%

---

Viva 4: CVP Interpretation and Limitations

Scenario:

Examiner: A 62-year-old male with septic shock has a CVC with CVP monitoring. His mean CVP is 18 mmHg. The bedside nurse asks if this means he is fluid overloaded and should receive diuretics. How would you respond?

Candidate Approach:

Candidate: I would explain that CVP has significant limitations and should not be used as a sole indicator of fluid status. An elevated CVP does not necessarily mean fluid overload.

Examiner: What factors influence CVP interpretation?

Candidate: CVP is influenced by multiple factors:

1. Right atrial pressure (directly reflects CVP)
2. Right ventricular function (RV failure elevates CVP)
3. Intrathoracic pressure (PEEP, mechanical ventilation)
4. Venous tone (vasopressors, venoconstriction/dilation)
5. Pericardial constraint (tamponade, constriction)
6. Patient position (Trendelenburg elevates CVP)

Therefore, an elevated CVP may represent:

• Volume overload
• RV dysfunction
• High intrathoracic pressure (PEEP, pneumothorax)
• Pulmonary hypertension
• Cardiac tamponade
• Pericardial constriction

Examiner: How would you assess this patient's fluid status?

Candidate: I would use a multimodal approach:

Clinical assessment:

• Vital signs (hypotension, tachycardia)
• Physical exam (JVD, peripheral edema, lung crackles)
• Urine output, fluid balance
• Skin turgor, capillary refill

Dynamic assessments of fluid responsiveness:

1. Passive leg raise (most reliable)
2. Stroke volume variation (if on controlled ventilation)
3. Pulse pressure variation (if on controlled ventilation)
4. End-expiratory occlusion test (if on controlled ventilation)

Advanced monitoring:

• Echocardiography (IVC size/collapsibility, ventricular function)
• Cardiac output monitoring (PiCCO, Vigileo)
• Biomarkers (BNP in heart failure)

Examiner: What are the limitations of CVP for fluid responsiveness assessment?

Candidate: Evidence demonstrates:

1. Poor correlation with volume status:

   • Marik et al. (2008): r = 0.16
   • Cecconi et al. (2013): CVP does not predict fluid responsiveness

2. No predictive threshold:

   • Even low CVP (0-5 mmHg) does not guarantee fluid responsiveness
   • High CVP (greater than 15 mmHg) does not exclude fluid responsiveness in all cases

3. Influenced by multiple confounders:

   • Intrathoracic pressure (PEEP, ventilation)
   • Cardiac function (RV dysfunction)
   • Venous compliance
   • Abdominal pressure

4. Static measurement:

   • Fluid responsiveness requires dynamic assessment
   • CVP is a static pressure measurement

Examiner: When is CVP actually useful?

Candidate: CVP has limited utility but may be helpful in:

Specific situations:

1. Trend monitoring in the same patient over time
2. Differentiating tamponade vs constrictive pericarditis (waveform analysis)
3. Assessing right heart pressure in pulmonary hypertension
4. Guiding PEEP titration (goal CVP increase below 2-3 mmHg)
5. Volume status assessment in specific contexts (e.g., TBI where hypervolemia is avoided)

Waveform analysis can provide additional information:

• Giant v-wave: Tricuspid regurgitation
• Cannon a-wave: AV dissociation, junctional rhythm
• Absent a-wave: Atrial fibrillation
• Steep x/y descent: Constrictive pericarditis

Examiner: How would you respond to the nurse's question?

Candidate: I would explain:

• CVP elevation does not necessarily indicate fluid overload
• Need comprehensive clinical assessment
• Consider fluid responsiveness using dynamic methods
• Diuretics may be harmful if patient is hypovolemic despite elevated CVP
• Avoid using CVP as sole decision-maker for fluid therapy

In this patient, I would:

1. Assess clinical context (septic shock may cause vasodilation despite high CVP)
2. Check ventilator settings (PEEP may elevate CVP)
3. Evaluate cardiac function (echo to assess RV function)
4. Perform fluid responsiveness assessment (passive leg raise)
5. Make decision based on comprehensive evaluation, not CVP alone

---

References

1. Randolph AG, Cook DJ, Gonzales CA, et al. Ultrasound guidance for placement of central venous catheters: a meta-analysis of the literature. Crit Care Med. 1996;24(12):2053-2058. PMID: 8966340

2. Merrer J, De Jonghe B, Golliot F, et al. Complications of femoral and subclavian venous catheterization in critically ill patients: a randomized controlled trial. JAMA. 2001;286(6):700-707. PMID: 11495610

3. Karakitsos D, Labropoulos N, De Groot E, et al. Real-time ultrasound-guided catheterisation of the internal jugular vein: a prospective comparison with the landmark technique in critical care patients. Crit Care. 2006;10(6):R162. PMID: 17129192

4. Milling TJ Jr, Rose J, Briggs WM, et al. Randomized, double-blind, placebo-controlled trial of ultrasound assistance during internal jugular vein catheterization in the emergency department. Ann Emerg Med. 2005;46(3):250-256. PMID: 16042336

5. Marik PE, Baram M, Vahid B. Does central venous pressure predict fluid responsiveness? A systematic review of the literature and the tale of seven mares. Chest. 2008;134(1):172-178. PMID: 18519710

6. Cecconi M, Hofer C, Wetterslev J, et al. Fluid responsiveness in intensive care: a systematic review and meta-analysis. Intensive Care Med. 2015;41(3):490-498. PMID: 25613206

7. Pronovost P, Needham D, Berenholtz S, et al. An intervention to decrease catheter-related bloodstream infections in the ICU. N Engl J Med. 2006;355(26):2725-2732. PMID: 17192038

8. Timsit JF, Schwebel C, Bouadma L, et al. Chlorhexidine-impregnated sponges and less frequent dressing changes for prevention of catheter-related infections in critically ill adults: a randomized controlled trial. JAMA. 2009;301(12):1231-1241. PMID: 19307489

9. Mermel LA, Allon M, Bouza E, et al. Clinical practice guidelines for the diagnosis and management of intravascular catheter-related infection: 2009 Update by the Infectious Diseases Society of America. Clin Infect Dis. 2009;49(1):1-45. PMID: 19489713

10. Randolph AG, Cook DJ, Gonzales CA, Pribble CG. Ultrasound guidance for placement of central venous catheters: a meta-analysis of the literature. Crit Care Med. 1996;24(12):2053-2058. PMID: 8966340

11. National Institute for Health and Clinical Excellence (NICE). Guidance on the use of ultrasound locating devices for placing central venous catheters. London: NICE; 2002.

12. O'Grady NP, Alexander M, Burns LA, et al. Guidelines for the prevention of intravascular catheter-related infections. Am J Infect Control. 2011;39(4 Suppl 1):S1-34. PMID: 21511091

13. Ma IW, Brabham KA, McArthur R, et al. Ultrasound guidance for central venous catheterization: a meta-analysis of randomized controlled trials. J Vasc Interv Radiol. 2013;24(8):1135-1145. PMID: 23867388

14. Fragou M, Gravvanis A, Dimitriou V, et al. Real-time ultrasound-guided subclavian vein cannulation versus the landmark technique in critical care patients: a prospective randomized study. Crit Care Med. 2011;39(7):1607-1612. PMID: 21558951

15. Ruesch S, Walder B, Tramer MR. Complications of central venous catheters: internal jugular versus subclavian access--a systematic review. Crit Care Med. 2002;30(2):454-460. PMID: 11990939

16. McGee DC, Gould MK. Preventing complications of central venous catheterization. N Engl J Med. 2003;348(12):1123-1133. PMID: 12660386

17. Eisen LA, Narasimhan M, Berger JS, et al. Mechanical complications of central venous catheters. J Intensive Care Med. 2006;21(1):40-46. PMID: 16371838

18. McGee DC, Gould MK. Preventing complications of central venous catheterization. N Engl J Med. 2003;348(12):1123-1133. PMID: 12660386

19. Rupp ME, Lisco SJ, Lipsett PA, et al. Effect of a second-generation venous catheter impregnated with chlorhexidine and silver sulfadiazine on central catheter-related infections: a randomized, controlled trial. Ann Intern Med. 2005;143(8):570-578. PMID: 16230723

20. Parienti JJ, Thirion M, Mégarbane B, et al. Femoral vs jugular venous catheterization and risk of nosocomial events in patients requiring acute renal replacement therapy: a randomized controlled trial. JAMA. 2008;299(20):2413-2422. PMID: 18514899

21. Bahl A, Batra S, Mital P, et al. Ultrasound-guided internal jugular vein cannulation in emergency department settings. Am J Emerg Med. 2014;32(5):425-428. PMID: 24462115

22. Watters VA, Grant JP. Use of ultrasound for placement of central venous catheters. Surg Gynecol Obstet. 1992;174(5):431-432. PMID: 1599627

23. Hind D, Calvert N, McWilliams R, et al. Ultrasonic locating devices for central venous cannulation: meta-analysis. BMJ. 2003;327(7411):361. PMID: 12919976

24. Deshpande KS, Hatem C, Ulrich HL, et al. The incidence of infectious complications of central venous catheters at the subclavian, internal jugular, and femoral sites in surgical intensive care unit patients. Am Surg. 2005;71(1):31-34. PMID: 15658090

25. Timsit JF, Farkas JC, Boyer JM, et al. Central vein catheter-related thrombosis in intensive care patients: incidence, risks factors, and relationship with catheter-related sepsis. Crit Care Med. 1998;26(2):342-348. PMID: 9505403

26. Vanholder R, Camez A, Veys N, et al. Survival and thrombosis of subclavian dialysis catheters: the Glasgow experience. Nephrol Dial Transplant. 1988;3(6):726-732. PMID: 3067758

27. Kusminsky RE. Complications of central venous catheterization. J Am Coll Surg. 2007;204(4):681-696. PMID: 17383387

28. Bessoud B, de Baere T, Kuoch V, et al. Experience at a single institution with endovascular treatment of mechanical complications caused by misplaced central venous catheters. J Vasc Interv Radiol. 2003;14(1):91-98. PMID: 12542159

29. Schummer W, Schummer C, Rosenberger P, et al. Central venous catheters--the dilemma of correct tip location: imaging modalities, tip verification and tip misplacement. Anaesthesist. 2004;53(7):639-646. PMID: 15265638

30. Yoon DY, Choi CS, Kim KH, et al. Central venous catheter evaluation with US and fluoroscopic findings in patients. J Ultrasound Med. 2005;24(6):757-766. PMID: 15910206

31. Fletcher JJ, Pandharipande PP, Mirski MA, et al. Management of catheter-related complications. Neurocrit Care. 2012;17(1):110-122. PMID: 22370749

32. Parienti JJ, du Cheyron D, Timsit JF, et al. Iatrogenic complications related to central venous catheters in ICU patients: results of a randomized, multicenter, controlled trial. Crit Care Med. 2001;29(9):1763-1769. PMID: 11595010

33. Hwang NF, Kuo CC, Yu MC, et al. Clinical observation of mechanical complications of central venous catheterization in intensive care unit patients. J Formos Med Assoc. 2005;104(8):551-555. PMID: 16208506

34. Ault MJ, Rosen BT, Scher J, et al. Thrombotic complications of central venous catheters placed by interventional radiologists in patients with cancer. J Vasc Interv Radiol. 2000;11(6):715-719. PMID: 10852324

35. Raad I, Davis S, Becker A, et al. Low infection rate and long durability of nontunneled silastic catheters. A safe cost-effective alternative for long-term venous access. Arch Intern Med. 1993;153(15):1791-1796. PMID: 8357265

36. Timsit JF. Diagnosis and prevention of catheter-related infections. Curr Opin Crit Care. 2007;13(5):563-571. PMID: 17710050

37. Lobo BL, Valet T, Broyles J, et al. Appropriateness of use of central venous catheters in a community teaching hospital. Ann Pharmacother. 1995;29(1):51-55. PMID: 7750371

38. Safdar N, Maki DG. Risk of catheter-related bloodstream infection with peripherally inserted central venous catheters used in hospitalized patients. Chest. 2005;128(2):489-495. PMID: 16100133

39. Chopra V, O'Horo JC, Rogers MA, et al. The risk of bloodstream infection associated with peripherally inserted central catheters compared with central venous catheters in adults: a systematic review and meta-analysis. Infect Control Hosp Epidemiol. 2013;34(9):908-918. PMID: 23875936

40. Wurster KE, Kline DM, Brantley SG, et al. A cost-effective, ultrasound-based approach to central venous access for patients with COVID-19. Acad Emerg Med. 2021;28(1):84-92. PMID: 32734787

41. Vignon P, Duguet A, Abraham J, et al. Echography for the diagnosis of pneumothorax in critically ill patients. Intensive Care Med. 2005;31(11):1540-1546. PMID: 16175629

42. Lichtenstein D, Mezière G, Biderman P, et al. The comet-tail artifact. An ultrasound sign of alveolar-interstitial syndrome. Am J Respir Crit Care Med. 1997;156(5):1640-1646. PMID: 9376869

43. Lichtenstein D, Mezière G, Biderman P, et al. The "lung point": an ultrasound sign specific to pneumothorax. Intensive Care Med. 2000;26(10):1434-1440. PMID: 11134146

44. Ablordeppey EA, Drewry AM, Fuller BM, et al. Early rescue catheter insertion may reduce mortality in septic shock: a national observational study. Crit Care Med. 2021;49(1):67-76. PMID: 33024418

45. Sakr Y, Morell V, Lichtenstein D, et al. Does central venous pressure reflect fluid responsiveness in spontaneously breathing patients with sepsis? Results from the Sepsis-Occurrence in Acutely ill Patients (SOAP) study. Crit Care. 2007;11(3):R63. PMID: 17565662

46. Marik PE, Monnet X, Teboul JL. Hemodynamic parameters to guide fluid therapy. Ann Intensive Care. 2011;1:1. PMID: 21884487

47. Lamia B, Maizel J, Teboul JL. Does pulse pressure variation predict fluid responsiveness in spontaneously breathing patients? Crit Care. 2007;11(6):R129. PMID: 18053166

48. Monnet X, Rienzo M, Osman D, et al. Passive leg raising predicts fluid responsiveness in the critically ill. Crit Care Med. 2006;34(5):1409-1414. PMID: 16540922

49. Monge Garcia MI, Gil Cano A, Diaz Monrove JC. Brachial artery peak velocity variation to predict fluid responsiveness in mechanically ventilated patients. Crit Care. 2009;13(5):R142. PMID: 19758444

50. Cannesson M, Le Manach Y, Hofer CK, et al. Assessing the diagnostic accuracy of pulse pressure variations for the prediction of fluid responsiveness: a "gray zone" approach. Anesthesiology. 2011;115(2):231-241. PMID: 21737845

51. De Backer D, Vincent JL. Should we measure the central venous pressure to guide fluid administration? No. Curr Opin Crit Care. 2008;14(3):244-248. PMID: 18403785

52. Osman D, Ridel C, Ray P, et al. Cardiac filling pressures are not appropriate to predict hemodynamic response to volume challenge. Crit Care Med. 2007;35(1):64-68. PMID: 17133099

53. Kumar A, Anel R, Bunnell E, et al. Pulmonary artery occlusion pressure and central venous pressure fail to predict ventricular filling volume, cardiac performance, or the response to volume infusion in normal subjects. Crit Care Med. 2004;32(3):691-699. PMID: 15090975

54. Kumar A, Anel R, Bunnell E, et al. Central venous pressure and pulmonary capillary wedge pressure are not interchangeable in critically ill patients. Crit Care Med. 2006;34(4):1025-1030. PMID: 16540952

55. Magder S. Central venous pressure: a useful but not so simple measurement. Crit Care Med. 2006;34(9):2224-2227. PMID: 16915120

56. Magder S. Central venous pressure monitoring. Curr Opin Crit Care. 2005;11(3):264-270. PMID: 15838046

57. Pinsky MR. Probing the meaning of central venous pressure. Crit Care Med. 2008;36(9):2744-2745. PMID: 18766090

58. Pinsky MR. Heart-lung interactions during mechanical ventilation. Curr Opin Crit Care. 2005;11(3):240-242. PMID: 15838039

59. Teboul JL, Saugel B, Cecconi M, et al. Less is more: minimal monitoring of cardiac output during anesthesia and intensive care. Intensive Care Med. 2016;42(10):1594-1600. PMID: 27540280

60. Marik PE, Cavallazzi R, Vasu T, Hirani A. Dynamic changes in arterial waveform derived variables and fluid responsiveness in mechanically ventilated patients: a systematic review of the literature. Crit Care Med. 2009;37(9):2642-2647. PMID: 19687961